APA (7th ed.) Citation

Lee, S., Roh, J., Park, J. S., Tuncay, I. O., Lee, W., Kim, J., . . . Lee, H. W. (2025). Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel. Cancer Research & Treatment, 57(2), 350. https://doi.org/10.4143/crt.2024.114

Chicago Style (17th ed.) Citation

Lee, Sangmoon, et al. "Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel." Cancer Research & Treatment 57, no. 2 (2025): 350. https://doi.org/10.4143/crt.2024.114.

MLA (9th ed.) Citation

Lee, Sangmoon, et al. "Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel." Cancer Research & Treatment, vol. 57, no. 2, 2025, p. 350, https://doi.org/10.4143/crt.2024.114.